More Articles

Proposed biosimilars guidelines for Chile Guidelines | Posted 20/01/2012

In October 2011, Chile’s Agencia Nacional de Medicamentos (ANAMED) released draft guidance for the evaluation of biosimilars in Chile

Shortages of ADHD drugs expected during 2012 Pharma News | Posted 20/01/2012

Drugs used to treat attention deficit hyperactivity disorder (ADHD) are in such short supply that FDA has reported that it receives hundreds of complaints from patients unable to fill their prescri...

Teva outlines expansion plans in Asia Generics/News | Posted 20/01/2012

Generics giant Teva is looking for deals in Asia, which the company believes will see strong future expansion in the use of generics.

Baxter and Momenta make biosimilars deal Biosimilars/News | Posted 20/01/2012

Baxter International (Baxter) and Momenta Pharmaceuticals (Momenta) announced on 22 December 2011 that they had entered into a global collaboration agreement to develop and commercialise biosimilars.

Generic nasal spray approved by FDA Generics/News | Posted 20/01/2012

India-based generics manufacturer Wockhardt announced on 10 January 2012 that it had received final approval from FDA for marketing a generic version of GlaxoSmithKline’s nasal spray allergy treatm...

Top developments in biosimilars during 2011 Biosimilars/General | Posted 13/01/2012

Over the past year, a lot has happened in the biosimilars industry.

Amgen finally jumps on biosimilars bandwagon Biosimilars/News | Posted 13/01/2012

Biotech giant Amgen and US generics manufacturer Watson Pharmaceuticals (Watson) announced on 19 December 2011 that the two companies had agreed to collaborate on the development and commercialisat...

Problematic pharma patent settlements decrease in the EU Reports | Posted 13/01/2012

A second round of European Commission (EC) monitoring concluded in early 2011. The main objectives of the monitoring exercise were to ‘better understand the use of these type of agreements in the E...